| scholarly article | Q13442814 |
| P2093 | author name string | Larissa A Shimoda | |
| Steven S Laurie | |||
| P2860 | cites work | Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia | Q74014913 |
| The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension | Q77318711 | ||
| Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung | Q77355275 | ||
| Pulmonary hypertension | Q80884934 | ||
| Reversal of pulmonary vascular remodeling in pulmonary hypertensive rats | Q83799677 | ||
| Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia | Q83977163 | ||
| HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing | Q24291102 | ||
| C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation | Q24291783 | ||
| FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity | Q24291819 | ||
| A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation | Q24294741 | ||
| Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing | Q24296765 | ||
| Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells | Q24314526 | ||
| HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation | Q24555773 | ||
| Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutation | Q24613597 | ||
| Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling | Q24647096 | ||
| Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay | Q24671869 | ||
| HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia | Q24671941 | ||
| A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development | Q24681396 | ||
| Hypoxia-inducible factors in physiology and medicine | Q27013770 | ||
| Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation | Q27860876 | ||
| Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation | Q28188357 | ||
| Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology | Q28218986 | ||
| Chronic hypoxia elevates intracellular pH and activates Na+/H+ exchange in pulmonary arterial smooth muscle cells | Q28257426 | ||
| Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha | Q28259513 | ||
| Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor | Q28271379 | ||
| Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases | Q28271592 | ||
| In vivo expression of mRNAs encoding hypoxia-inducible factor 1 | Q28286675 | ||
| Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha | Q28508120 | ||
| Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2 | Q28508549 | ||
| Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death | Q28510984 | ||
| An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension | Q28576675 | ||
| HIF-1 alpha is required for solid tumor formation and embryonic vascularization. | Q28588778 | ||
| Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1alpha | Q28591038 | ||
| Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment | Q29346986 | ||
| Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics | Q29615944 | ||
| Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway | Q29617805 | ||
| Updated clinical classification of pulmonary hypertension. | Q30378433 | ||
| Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth | Q33385608 | ||
| Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells | Q33703652 | ||
| Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization | Q33868764 | ||
| Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1 | Q34052670 | ||
| Hypoxia: adapting to high altitude by mutating EPAS-1, the gene encoding HIF-2α. | Q34196563 | ||
| The length of peptide substrates has a marked effect on hydroxylation by the hypoxia-inducible factor prolyl 4-hydroxylases | Q34553660 | ||
| Acute and chronic hypoxic pulmonary vasoconstriction: a central role for endothelin-1? | Q34749328 | ||
| Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization | Q35006577 | ||
| Activation of K+ channels: an essential pathway in programmed cell death | Q35600688 | ||
| The endothelin system in pulmonary arterial hypertension | Q35635106 | ||
| Silencing of sodium-hydrogen exchanger 1 attenuates the proliferation, hypertrophy, and migration of pulmonary artery smooth muscle cells via E2F1 | Q35684903 | ||
| Digoxin inhibits development of hypoxic pulmonary hypertension in mice | Q35709083 | ||
| Hypoxia, leukocytes, and the pulmonary circulation | Q36009074 | ||
| Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning | Q36068993 | ||
| Hypoxia-induced migration in pulmonary arterial smooth muscle cells requires calcium-dependent upregulation of aquaporin 1 | Q36178060 | ||
| Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis | Q36220525 | ||
| Developmental regulation of hypoxia-inducible factor 1 and prolyl-hydroxylases in pulmonary vascular smooth muscle cells | Q36277024 | ||
| Hypoxic pulmonary vasoconstriction: mechanisms and controversies | Q36299224 | ||
| Regulating cellular oxygen sensing by hydroxylation. | Q36509378 | ||
| Vascular remodeling in pulmonary hypertension | Q36644607 | ||
| Ca2+ channels and chronic hypoxia | Q36645336 | ||
| Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1. | Q36764714 | ||
| mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects | Q36788720 | ||
| Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation | Q36928937 | ||
| Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer | Q37033660 | ||
| The increase in pulmonary arterial pressure caused by hypoxia depends on iron status | Q37127689 | ||
| Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis | Q37271066 | ||
| Age-dependent impairment of HIF-1alpha expression in diabetic mice: Correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells | Q37275834 | ||
| HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice | Q37286696 | ||
| Hypoxia inhibits gene expression of voltage-gated K+ channel alpha subunits in pulmonary artery smooth muscle cells | Q37374378 | ||
| Regulation of oxygen homeostasis by hypoxia-inducible factor 1. | Q37443475 | ||
| Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. | Q37487004 | ||
| Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis | Q37506973 | ||
| Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. | Q37596193 | ||
| Intermittent hypoxia-mediated plasticity of acute O2 sensing requires altered red-ox regulation by HIF-1 and HIF-2. | Q37618861 | ||
| Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α. | Q37688525 | ||
| Hypoxia-inducible factor-1α in pulmonary artery smooth muscle cells lowers vascular tone by decreasing myosin light chain phosphorylation | Q37734664 | ||
| Hypoxia-inducible factor 1: Regulator of mitochondrial metabolism and mediator of ischemic preconditioning | Q37781873 | ||
| Hypoxia and inflammation | Q37842498 | ||
| Hypoxia-induced inflammation in the lung: a potential therapeutic target in acute lung injury? | Q38054037 | ||
| The role of hypoxia in pulmonary vascular diseases: a perspective | Q38078782 | ||
| Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials | Q38378487 | ||
| The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice. | Q39250750 | ||
| Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia | Q39752665 | ||
| Nuclear oxygen sensing: induction of endogenous prolyl-hydroxylase 2 activity by hypoxia and nitric oxide | Q39942436 | ||
| RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha | Q40179965 | ||
| Hypoxia and the lung: beyond hypoxic vasoconstriction | Q40211828 | ||
| 55th Bowditch Lecture: Effects of chronic hypoxia on the pulmonary circulation: role of HIF-1. | Q42415178 | ||
| Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats | Q42447186 | ||
| Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension | Q42464729 | ||
| Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular Ca2+ in pulmonary arterial smooth muscle cells | Q42495592 | ||
| PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats | Q43687845 | ||
| Capacitative calcium entry and TRPC channel proteins are expressed in rat distal pulmonary arterial smooth muscle | Q44691480 | ||
| Endothelin-1 mediates hypoxia-induced inhibition of voltage-gated K+ channel expression in pulmonary arterial myocytes | Q46861437 | ||
| Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. | Q52195684 | ||
| HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. | Q53618498 | ||
| Endothelin-1 induces hypoxia inducible factor 1α expression in pulmonary artery smooth muscle cells. | Q54479395 | ||
| The pathophysiological basis of chronic hypoxic pulmonary hypertension in the mouse: vasoconstrictor and structural mechanisms contribute equally. | Q54527080 | ||
| Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2 alpha mutation. | Q55050250 | ||
| Hypoxic pulmonary vasoconstriction | Q57099542 | ||
| A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels | Q69851259 | ||
| The role of Na+/H+ exchange and growth factors in pulmonary artery smooth muscle cell proliferation | Q71078181 | ||
| Membrane properties of smooth muscle cells in pulmonary hypertensive rats | Q71604177 | ||
| Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia | Q72464327 | ||
| Stimulation of calcium entry is prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells | Q72607639 | ||
| Chronic hypoxia is associated with reduced delayed rectifier K+ current in rat pulmonary artery muscle cells | Q72764843 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | 867-874 | |
| P577 | publication date | 2013-12-12 | |
| P1433 | published in | Journal of Applied Physiology | Q1091719 |
| P1476 | title | HIF and pulmonary vascular responses to hypoxia | |
| P478 | volume | 116 |
| Q49663303 | Actin Polymerization Contributes to Enhanced Pulmonary Vasoconstrictor Reactivity Following Chronic Hypoxia. |
| Q35836904 | Anaemia in kidney disease: harnessing hypoxia responses for therapy |
| Q35223470 | Association between serum concentrations of hypoxia inducible factor responsive proteins and excessive erythrocytosis in high altitude Peru |
| Q36951774 | Clinical iron deficiency disturbs normal human responses to hypoxia |
| Q35094143 | Contrasting effects of ascorbate and iron on the pulmonary vascular response to hypoxia in humans |
| Q38266683 | Control of vascular smooth muscle function by Src-family kinases and reactive oxygen species in health and disease. |
| Q57784529 | Divergent Changes of p53 in Pulmonary Arterial Endothelial and Smooth Muscle Cells Involved in the Development of Pulmonary Hypertension |
| Q47598587 | Endothelial HIF-2α Contributes to Severe Pulmonary Hypertension by Inducing Endothelial-to-Mesenchymal Transition. |
| Q88540298 | Gestational Hypoxia and Developmental Plasticity |
| Q26862091 | HIF hydroxylase pathways in cardiovascular physiology and medicine |
| Q38668387 | Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming |
| Q34360748 | Human high-altitude adaptation: forward genetics meets the HIF pathway. |
| Q50047956 | Hypoxia induces pulmonary arterial fibroblast proliferation, migration, differentiation and vascular remodeling via the PI3K/Akt/p70S6K signaling pathway |
| Q43182905 | Hypoxia inducible factor signaling and experimental persistent pulmonary hypertension of the newborn |
| Q38740776 | Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin? |
| Q64070655 | Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism |
| Q27026931 | Hypoxia-inducible factors and hypertension: lessons from sleep apnea syndrome |
| Q28080704 | Iron, oxygen, and the pulmonary circulation |
| Q38441794 | Lungs at high-altitude: genomic insights into hypoxic responses |
| Q47631019 | Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension |
| Q58592398 | Metabolism and Redox in Pulmonary Vascular Physiology and Pathophysiology |
| Q37354043 | Microparticulate/Nanoparticulate Powders of a Novel Nrf2 Activator and an Aerosol Performance Enhancer for Pulmonary Delivery Targeting the Lung Nrf2/Keap-1 Pathway |
| Q59358681 | New mouse model of pulmonary hypertension induced by respiratory syncytial virus bronchiolitis |
| Q26795484 | Oxygen Sensing and Homeostasis |
| Q36549129 | Peroxisome Proliferator-Activated Receptor γ-Mediated Inhibition on Hypoxia-Triggered Store-Operated Calcium Entry. A Caveolin-1-Dependent Mechanism |
| Q36352098 | Profiling the role of mammalian target of rapamycin in the vascular smooth muscle metabolome in pulmonary arterial hypertension |
| Q51518603 | Punicalagin Prevents Hypoxic Pulmonary Hypertension via Anti-Oxidant Effects in Rats. |
| Q46776309 | Pyk2 aggravates hypoxia-induced pulmonary hypertension by activating HIF-1α. |
| Q90658343 | Redox Regulation of Ion Channels and Receptors in Pulmonary Hypertension |
| Q49566048 | Regulation, signalling and functions of hormonal peptides in pulmonary vascular remodelling during hypoxia |
| Q36878827 | The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice. |
| Q89983220 | Tumor-educated B cells promote renal cancer metastasis via inducing the IL-1β/HIF-2α/Notch1 signals |
| Q28076917 | Unique aspects of the developing lung circulation: structural development and regulation of vasomotor tone |
| Q38710779 | Vitamin C: the known and the unknown and Goldilocks |
| Q37556377 | miR-17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia-Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation |
Search more.